Pharma 2023: New Rules for Clinical Lay Summaries in EU
Estelle Jobson, EUPATI alumna, patient expert and health communications professional discusses changes to the EU's requirements for clinical trial lay summaries.
Estelle Jobson, EUPATI alumna, patient expert and health communications professional discusses changes to the EU's requirements for clinical trial lay summaries at Pharma 2023.
EUPATI offers the following resources for sponsors looking for information on lay summaries:
Patients Involved – Patient feedback on a plain language summary of results
Good Lay Summary Practice – This “Good Lay Summary Practice” is identical to the content of the Good Lay Summary Practice Guidance published on EudraLex, Volume 10, 4 October 2021.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
SCOPE Summit 2025 Opening Keynote Panel: What Do Real Patients Actually Talk About?
February 3rd 2025Interactive panel on day 1 of SCOPE Summit 2025 highlighted the need for inclusive narratives, social listening to understand patient experiences, and the role of advocacy groups in opening doors to clinical trials.
